Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CA Stock MarketDetailed Quotes
Voyageur Pharmaceuticals Ltd (VM)
- 0.095
- -0.005-5.00%
15min DelayMarket Closed May 13 16:00 ET
17.05MMarket Cap-9.50P/E (TTM)
0.100High0.095Low123.04KVolume0.100Open0.100Prev Close11.69KTurnover0.36052wk High0.08%Turnover Ratio179.48MShares0.09552wk Low-0.01EPS TTM15.51MFloat Cap0.400Historical HighLossP/E (Static)163.28MShs Float0.035Historical Low-0.02EPS LYR5.00%Range %--Dividend TTM23.75P/B1Lot Size--Div Yield TTM
Voyageur Pharmaceuticals Ltd (VM) Cash Flow
Quarterly+Annual
YOY
| (Q1)Feb 28, 2026 | (FY)Nov 30, 2025 | (Q4)Nov 30, 2025 | (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 83.95%-165.13K | -856.96%-2.89M | -1,299.10%-369.98K | -2,352.15%-883.27K | -222.62%-610.69K | -462.00%-1.03M | 69.50%-302.29K | -32.79%30.86K | 146.78%39.22K | 60.49%-189.29K |
| Net income from continuing operations | 23.26%-627.42K | -106.92%-3.53M | -88.86%-865.95K | -265.09%-1.3M | 3.23%-544.25K | -148.54%-817.56K | -21.99%-1.71M | -62.40%-458.51K | -193.05%-357.39K | 9.51%-562.4K |
| Operating gains losses | -186.57%-8.03K | -98.03%20 | 277.46%9.05K | -287.34%-4.8K | -321.23%-13.51K | 642.16%9.28K | 181.97%1.01K | ---5.1K | ---1.24K | --6.11K |
| Depreciation and amortization | 0.00%283 | -27.83%1.13K | -27.81%283 | -27.99%283 | -27.55%284 | -27.99%283 | -28.15%1.57K | -28.21%392 | -28.15%393 | -28.21%392 |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | -83.66%7.94K | ---- | ---- | ---- |
| Remuneration paid in stock | -88.93%43.75K | 94.09%809.68K | -508.64%-125.52K | 229.72%241.24K | 24.68%298.67K | 216.07%395.3K | 78.25%417.16K | -268.83%-20.62K | 369.35%73.16K | 7.80%239.55K |
| Change In working capital | 169.19%426.29K | -117.50%-171.07K | 20.80%612.15K | -43.01%184.82K | -376.95%-351.88K | -3,314.81%-616.15K | 787.21%977.27K | 99.81%506.76K | 299.91%324.29K | 231.33%127.05K |
| -Change in receivables | -73.30%-31.17K | -408.26%-81.98K | -15.84%-16.88K | -193.23%-30.71K | -79.08%-16.4K | -199.51%-17.99K | -33.85%-16.13K | -56.94%-14.58K | -159.10%-10.47K | -43.12%-9.16K |
| -Change in inventory | ---88.26K | 131.24%17.65K | 283.44%103.64K | ---68.11K | ---17.88K | --0 | ---56.5K | ---56.5K | --0 | --0 |
| -Change in prepaid assets | 529.37%110.33K | -112.61%-72.03K | -2,069.10%-98.26K | 10.62%50.86K | -97.72%1.06K | 80.41%-25.7K | -166.27%-33.88K | -70.47%4.99K | 494.81%45.98K | -4.55%46.33K |
| -Change in payables and accrued expense | 153.00%488.92K | -112.13%-131.48K | -8.03%526.87K | -19.40%232.77K | -65.12%31.35K | -797.39%-922.47K | 1,424.80%1.08M | 132.85%572.85K | 284.94%288.78K | 164.71%89.88K |
| -Change in other current liabilities | -115.29%-53.51K | --96.77K | ---- | ---- | ---- | --350K | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 83.95%-165.13K | -856.96%-2.89M | -1,299.10%-369.98K | -2,352.14%-883.27K | -222.62%-610.69K | -462.00%-1.03M | 69.50%-302.29K | -32.79%30.86K | 146.78%39.22K | 60.49%-189.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 38.21%-26.22K | -62.71%-270.02K | -160.53%-92.02K | -109.19%-115.03K | 46.08%-20.54K | -13.01%-42.43K | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K |
| Net other investing changes | 38.21%-26.22K | -62.71%-270.02K | -160.53%-92.02K | -109.19%-115.03K | 46.08%-20.54K | -13.01%-42.43K | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 38.21%-26.22K | -62.71%-270.02K | -160.53%-92.02K | -109.19%-115.03K | 46.08%-20.54K | -13.01%-42.43K | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 416.73%3.26M | -228.20%-214.1K | 27,643.40%1.56M | 4,133.88%370.63K | 229.87%1.54M | -44.41%631.73K | 1,436.00%167K | -65.54%5.63K | -138.59%-9.19K |
| Net common stock issuance | --0 | 39.42%913.88K | --0 | --0 | --0 | 85.14%913.88K | -45.37%655.5K | 1,436.00%167K | -96.76%530 | -46.30%-5.63K |
| Proceeds from stock option exercised by employees | --0 | 47,542.08%2.43M | --12.77K | 31,871.12%1.63M | --90.18K | --696.9K | --5.1K | --0 | --5.1K | --0 |
| Net other financing activities | ---- | -181.32%-81.23K | ---226.87K | ---68.74K | 7,991.31%280.46K | -160.96%-66.08K | 54.49%-28.88K | --0 | --0 | ---3.55K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 416.73%3.26M | -228.20%-214.1K | 27,643.40%1.56M | 4,133.88%370.63K | 229.87%1.54M | -44.41%631.73K | 1,436.00%167K | -65.54%5.63K | -138.59%-9.19K |
| Net cash flow | ||||||||||
| Beginning cash position | 61.29%267.05K | 7,840.96%165.57K | 30,975.95%943.16K | 2,773.30%378.39K | 155.85%638.99K | 7,840.96%165.57K | -93.39%2.09K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K |
| Current changes in cash | -140.42%-191.35K | -37.92%101.49K | -515.98%-676.1K | 5,673.02%564.77K | -10.15%-260.6K | 91.15%473.42K | 654.63%163.48K | 79,966.01%162.53K | 91.71%-10.13K | 55.18%-236.58K |
| End cash Position | -88.15%75.71K | 61.29%267.05K | 61.29%267.05K | 30,975.95%943.16K | 2,773.30%378.39K | 155.85%638.99K | 7,840.96%165.57K | 7,840.96%165.57K | 61.26%3.04K | -89.39%13.17K |
| Free cash from | 83.95%-165.13K | -856.96%-2.89M | -1,299.10%-369.98K | -2,352.14%-883.27K | -222.62%-610.69K | -462.00%-1.03M | 69.50%-302.29K | -32.79%30.86K | 146.78%39.22K | 60.49%-189.29K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm